1189 related articles for article (PubMed ID: 29054499)
1. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
[TBL] [Abstract][Full Text] [Related]
2. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
Sommerfeld M; Cui Y; Schmalfuß S
Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.
Bass K; Farkas D; Longest W
AAPS PharmSciTech; 2019 Nov; 20(8):329. PubMed ID: 31676991
[TBL] [Abstract][Full Text] [Related]
4. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
5. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
Milenkovic J; Alexopoulos AH; Kiparissides C
Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
[TBL] [Abstract][Full Text] [Related]
6. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
Tian G; Hindle M; Lee S; Longest PW
Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
[TBL] [Abstract][Full Text] [Related]
7. Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.
Longest W; Farkas D; Bass K; Hindle M
Pharm Res; 2019 May; 36(8):110. PubMed ID: 31139939
[TBL] [Abstract][Full Text] [Related]
8. On the Use of Computational Fluid Dynamics (CFD) Modelling to Design Improved Dry Powder Inhalers.
Fletcher DF; Chaugule V; Gomes Dos Reis L; Young PM; Traini D; Soria J
Pharm Res; 2021 Feb; 38(2):277-288. PubMed ID: 33575958
[TBL] [Abstract][Full Text] [Related]
9. Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.
Longest PW; Tian G; Khajeh-Hosseini-Dalasm N; Hindle M
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):461-481. PubMed ID: 27082824
[TBL] [Abstract][Full Text] [Related]
10. Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.
Longest W; Hassan A; Farkas D; Hindle M
Pharm Res; 2022 Feb; 39(2):295-316. PubMed ID: 35147870
[TBL] [Abstract][Full Text] [Related]
11. Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of impaction effects for agglomerated systems.
Wong W; Fletcher DF; Traini D; Chan HK; Crapper J; Young PM
J Pharm Sci; 2011 Jul; 100(7):2744-54. PubMed ID: 21360707
[TBL] [Abstract][Full Text] [Related]
12. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
Delvadia RR; Longest PW; Hindle M; Byron PR
J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
[TBL] [Abstract][Full Text] [Related]
13. Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations.
Benque B; Khinast JG
Eur J Pharm Sci; 2021 Jan; 156():105574. PubMed ID: 32980431
[TBL] [Abstract][Full Text] [Related]
14. Computational modelling and experimental validation of drug entrainment in a dry powder inhaler.
Kopsch T; Murnane D; Symons D
Int J Pharm; 2018 Dec; 553(1-2):37-46. PubMed ID: 30316002
[TBL] [Abstract][Full Text] [Related]
15. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
Walenga RL; Longest PW
J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
[TBL] [Abstract][Full Text] [Related]
16. Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
de Boer AH; Hagedoorn P; Woolhouse R; Wynn E
J Pharm Pharmacol; 2012 Sep; 64(9):1316-25. PubMed ID: 22881443
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhaler aerosol deposition in a model of tracheobronchial airways: Validating CFD predictions with in vitro data.
Ahookhosh K; Saidi M; Aminfar H; Mohammadpourfard M; Hamishehkar H; Yaqoubi S
Int J Pharm; 2020 Sep; 587():119599. PubMed ID: 32663586
[TBL] [Abstract][Full Text] [Related]
18. Computational investigation of particle penetration and deposition pattern in a realistic respiratory tract model from different types of dry powder inhalers.
Kim YH; Li DD; Park S; Yi DS; Yeoh GH; Abbas A
Int J Pharm; 2022 Jan; 612():121293. PubMed ID: 34808267
[TBL] [Abstract][Full Text] [Related]
19. Dry powder inhaler device influence on carrier particle performance.
Donovan MJ; Kim SH; Raman V; Smyth HD
J Pharm Sci; 2012 Mar; 101(3):1097-107. PubMed ID: 22095397
[TBL] [Abstract][Full Text] [Related]
20. Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.
Bass K; Longest W
AAPS PharmSciTech; 2020 May; 21(5):157. PubMed ID: 32451773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
